Harnessing the Potential of Molecular Glues to Target & Degrade Proteins Across CNS Indications
Time: 1:01 pm
day: Pre-Conference Day
Details:
CNS disease targets possess the hallmarks of molecular glue’s ability to address
hard-to-drug targets, furthered still with molecular glue’s smaller size being
advantageous to penetrating the BBB. Join this workshop to debate the ability, current
status, and major challenges to overcome to demonstrate the untapped potential of
molecular glue applications to the CNS.
Highlights include:
- Debating best methods to redirect molecular glues to specific CNS targets – what are the exacerbated challenges?
- Showcasing preclinical data of molecular glues targeting neuroinflammation
- Discussing strategies to design molecular glues for therapeutic-specific approaches
